Latest Federal Court Cases: Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
By EsqSocial Corporation 15/04/25
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd., Appeal No. 2023-1977 (Fed. Cir. Apr. 8, 2025) In our Case of the Week, the Federal Circuit affirmed that defendant Alkem’s proposed generic antibiotic did not infringe claims of a patent that covers appellant Azurity’s Firvanq® medication. The Court found that during prosecution of a related patent, Azurity had made “sweeping” disclaimers of any formulation that contains propylene glycol, an ingredient used as a solvent and in certain...
By: Schwabe, Williamson & Wyatt PC